Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Medical Access ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   0.0% 16.1% 11.3% 14.8% 17.5% 12.4% 20.5% 20.5%   Credit score (0-100)   0 11 20 13 8 19 5 5   Credit rating   N/A BB BB BB B BB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   0.0 183 426 1,323 1,329 1,368 0.0 0.0   EBITDA   0.0 183 -11.6 302 391 358 0.0 0.0   EBIT   0.0 149 -123 102 75.1 93.7 0.0 0.0   Pre-tax profit (PTP)   0.0 139.3 -168.2 26.0 7.7 -1.9 0.0 0.0   Net earnings   0.0 142.6 -99.4 19.1 6.1 -7.9 0.0 0.0   Pre-tax profit without non-rec. items   0.0 139 -168 26.0 7.7 -1.9 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   0.0 185 85.2 104 110 103 -520 -520   Interest-bearing liabilities   0.0 0.0 0.0 81.5 108 109 520 520   Balance sheet total (assets)   0.0 905 1,193 1,811 1,252 1,315 0.0 0.0   Net Debt   0.0 -70.2 -26.4 -35.2 7.5 -276 520 520     See the entire balance sheet 1000.0 Volume  2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   0.0 183 426 1,323 1,329 1,368 0.0 0.0   Gross profit growth   0.0% 0.0% 132.8% 210.4% 0.4% 3.0% -100.0% 0.0%   Employees   0 0 1 3 2 2 0 0   Employee growth %   0.0% 0.0% 0.0% 200.0% -33.3% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   0 905 1,193 1,811 1,252 1,315 0 0   Balance sheet change%   0.0% 0.0% 31.8% 51.8% -30.8% 5.0% -100.0% 0.0%   Added value   0.0 183.1 -11.6 302.0 275.1 357.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 446 263 178 -631 -437 -744 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   0.0 1.0 -1.0 1.0 2.0 3.0 0.0 0.0   1000.0 Profitability  2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   0.0% 81.3% -28.8% 7.7% 5.7% 6.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   0.0% 16.4% -11.7% 6.8% 4.9% 9.2% 0.0% 0.0%   ROI %   0.0% 80.6% -36.3% 19.6% 19.7% 32.9% 0.0% 0.0%   ROE %   0.0% 77.3% -73.6% 20.1% 5.7% -7.4% 0.0% 0.0%   1000.0 Solidity  2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   0.0% 20.4% 7.1% 5.8% 8.8% 7.8% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   0.0% -38.3% 227.9% -11.7% 1.9% -77.1% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 78.1% 97.9% 106.1% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 186.7% 71.6% 67.1% 0.0% 0.0%   1000.0 Liquidity  2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   0.0 0.6 0.4 0.3 0.2 0.7 0.0 0.0   Current Ratio   0.0 0.6 0.4 0.3 0.2 0.7 0.0 0.0   Cash and cash equivalent   0.0 70.2 26.4 116.7 100.6 384.5 0.0 0.0   1000.0 Capital use efficiency  2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   0.0 -316.4 -404.2 -893.5 -661.1 -159.0 -259.9 -259.9   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 -12 101 138 179 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 -12 101 195 179 0 0   EBIT / employee   0 0 -123 34 38 47 0 0   Net earnings / employee   0 0 -99 6 3 -4 0 0